The growth rate of optic pathway gliomas is unpredictable and quite variable, especially in children with neurofibromatosis Type 1 (NF1). Typically, only symptomatic and/or radiographically growing tumors require treatment, and observation is the accepted first-line option. Neurosurgical Focus
Chemotherapy is the first-line treatment for progressive optic pathway tumors, and radiation therapy is reserved for patients with progressive disease who are older than 57 years. Surgery is reserved for large tumors causing mass effect or hydrocephalus. Neurosurgical Focus
Optic nerve sheath meningiomas (ONSMs) are rare tumors of the anterior visual pathway. Untreated ONSMs almost always lead to progressive visual decline. The authors review current treatment modalities for ONSMs, with an emphasis on fractionated stereotactic radiotherapy. Neurosurgical Focus
The AAO 2007 featured updates on microbial keratitis as well as advances in medical and surgical approaches to cornea and external disease. Medscape Ophthalmology
The AAO 2007 featured updates on microbial keratitis as well as advances in medical and surgical approaches to cornea and external disease. Medscape Ophthalmology
Recent advancements in the speed and accuracy of data acquisition and resolution of neuroimaging and interventional techniques have revolutionized the early anatomical and functional diagnosis, prognosis, and treatment of many neuroophthalmological disorders. Neurosurgical Focus
Diabetic maculopathy remains the major cause of loss of vision in diabetes. This case series examines whether statins may aid in the management of maculopathy by reducing macular oedema. The British Journal of Diabetes and Vascular Disease
Retinal microvascular changes are associated with increased coronary artery calcification (CAC), an indicator of subclinical coronary macrovascular disease, findings from the prospective Multi-Ethnic Study of Atherosclerosis (MESA) suggest. Reuters Health Information
